Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease

Kidney International

Volumn 74, Issue 3, 2008, Pages 389-390

  Rouached, Mervet ^a   El Kadiri Boutchich, Sarra ^a   Al Rifai, Assem Mohamed ^a   Garabédian, Michèle ^b   Fournier, Albert ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; CALCIUM CARBONATE; COLECALCIFEROL; ERGOCALCIFEROL; PARATHYROID HORMONE; PHOSPHATE; PLACEBO; VITAMIN D;

BLOOD VESSEL CALCIFICATION; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; GLOMERULUS FILTRATION RATE; HORMONE RELEASE; HUMAN; HYPERPARATHYROIDISM; KIDNEY FAILURE; LETTER; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

EID: 47349085402     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.169     Document Type: Letter

References (3)

1. Levin A, Bakris GL, Molitch M et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007; 71: 31-38.
2. 3 and 25(OH) vitamin D3. Kidney Int Suppl 1988; 24: S178-S179.
3. Fournier A, Harbouche L, Mansour J et al. Impact of calcium and vitamin D therapy on arterial and cardiac disease in young adults with childhood-onset end stage renal disease. Nephrol Dial Transplant 2007; 22: 956-957; author reply 957-958.